Rhenman & Partners Asset Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Rhenman & Partners Asset Management’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-277,800	Closed	-$1M	–	105
2019 Q3	$1M	Hold	277,800	–	–	0.13%	79
2019 Q2	$745K	Hold	277,800	–	–	0.08%	76
2019 Q1	$822K	Sell	277,800 -125,000	-31%	-$307K	0.1%	74
2018 Q4	$640K	Sell	402,800 -215,000	-35%	-$608K	0.07%	73
2018 Q3	$2.27M	Hold	617,800	–	–	0.23%	67
2018 Q2	$1.75M	Sell	617,800 -50,000	-7%	-$170K	0.18%	69
2018 Q1	$2.48M	Hold	667,800	–	–	0.31%	65
2017 Q4	$1.92M	Sell	667,800 -182,200	-21%	-$662K	0.26%	73
2017 Q3	$3.82M	Buy	850,000 +684,000	+412%	+$3.04M	0.49%	68
2017 Q2	$762K	Hold	166,000	–	–	0.11%	85
2017 Q1	$699K	Hold	166,000	–	–	0.11%	84
2016 Q4	$686K	Sell	166,000 -100,000	-38%	-$532K	0.13%	85
2016 Q3	$2.15M	Hold	266,000	–	–	0.34%	76
2016 Q2	$2.08M	Hold	266,000	–	–	0.37%	75
2016 Q1	$2.05M	Hold	266,000	–	–	0.41%	76
2015 Q4	$2.87M	Sell	266,000 -14,000	-5%	-$127K	0.43%	69
2015 Q3	$1.94M	Hold	280,000	–	–	0.31%	80
2015 Q2	$2.48M	Hold	280,000	–	–	0.3%	90
2015 Q1	$2.76M	Sell	280,000 -88,000	-24%	-$1.1M	0.47%	76
2014 Q4	$4.51M	Buy	368,000 +168,000	+84%	+$2.05M	1.31%	28
2014 Q3	$2M	Sell	200,000 -130,000	-39%	-$1.21M	0.58%	70
2014 Q2	$2.5M	Buy	+330,000	New	+$1.32M	0.74%	50

Other funds holding ACHN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rhenman & Partners Asset Management's ACHN Position: Q4 2019 in Review

Rhenman & Partners Asset Management sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 277,800 shares — an estimated $1M sold.

Rhenman & Partners Asset Management first reported a position in ACHN in Q2 2014 and held it in 22 quarters. The position peaked at $4.51M in Q4 2014. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

Rhenman & Partners Asset Management reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Rhenman & Partners Asset Management sold 277,800 Achillion Pharmaceuticals shares in Q4 2019, an estimated $1M.
Rhenman & Partners Asset Management first reported a position in Achillion Pharmaceuticals in Q2 2014 and held it in 22 quarters.
Rhenman & Partners Asset Management's Achillion Pharmaceuticals position peaked at $4.51M in Q4 2014.
132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.